{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:55:34Z","timestamp":1766555734852,"version":"3.48.0"},"reference-count":15,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2024,1,15]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1136\/ejhpharm-2023-003914","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T13:20:47Z","timestamp":1706188847000},"page":"90-93","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Management of heparin-induced thrombocytopenia during extracorporeal membrane oxygenation support: a case of neutropenia caused by argatroban anticoagulation"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-1643","authenticated-orcid":false,"given":"Javier","family":"G\u00f3mez-Alonso","sequence":"first","affiliation":[{"name":"Pharmacy, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mart\u00ednez Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Critical Care Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo Andr\u00e9s","family":"Bonilla Rojas","sequence":"additional","affiliation":[{"name":"Critical Care Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor Carlos","family":"Garc\u00eda D\u00edaz","sequence":"additional","affiliation":[{"name":"Pharmacy, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Riera del Brio","sequence":"additional","affiliation":[{"name":"Critical Care Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aa Queralt","family":"Gorgas Torner","sequence":"additional","affiliation":[{"name":"Pharmacy, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Dom\u00e9nech-Moral","sequence":"additional","affiliation":[{"name":"Pharmacy, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"2025122321350576000_33.1.90.1","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-017-0235-y","article-title":"Argatroban for an alternative anticoagulant in HIT during ECMO","volume":"5","author":"Roug\u00e9","year":"2017","journal-title":"J Intensive Care"},{"key":"2025122321350576000_33.1.90.2","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001230"},{"key":"2025122321350576000_33.1.90.3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5492\/wjccm.v8.i6.87","article-title":"Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation","volume":"8","author":"Burstein","year":"2019","journal-title":"World J Crit Care Med"},{"key":"2025122321350576000_33.1.90.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-443051"},{"key":"2025122321350576000_33.1.90.5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12055-021-01176-3","article-title":"Anticoagulation in ECMO patients: an overview","volume":"37","author":"Kumar","year":"2021","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"2025122321350576000_33.1.90.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.04.014"},{"key":"2025122321350576000_33.1.90.7","unstructured":"US Food and Drug Administration . Argatroban injection in 0.9% sodium chloride for intravenous infusion only. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022485lbl.pdf [Accessed 30 Mar 2023]."},{"key":"2025122321350576000_33.1.90.8","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025122321350576000_33.1.90.9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.revmed.2021.08.011","article-title":"La thrombop\u00e9nie induite par h\u00e9parine: mise au point","volume":"43","author":"Camoin-Jau","year":"2022","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"2025122321350576000_33.1.90.10","unstructured":"Manufacturer Arganova (Argatroban) information. n.d. Available: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/74548\/74548_ft.pdf"},{"key":"2025122321350576000_33.1.90.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-016-0189-6","article-title":"Management of neutropenic patients in the intensive care unit (newborns excluded) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)","volume":"6","author":"Schnell","year":"2016","journal-title":"Ann Intensive Care"},{"key":"2025122321350576000_33.1.90.12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12165"},{"key":"2025122321350576000_33.1.90.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12959-022-00401-2","article-title":"Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"20","author":"M\u2019Pembele","year":"2022","journal-title":"Thromb J"},{"key":"2025122321350576000_33.1.90.14","unstructured":"US Food and Drug Administration . FDA Adverse Event Reporting System (FAERS) Public Dashboard. n.d. Available: https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard"},{"key":"2025122321350576000_33.1.90.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-003914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T05:36:06Z","timestamp":1766554566000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-003914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,23]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/ejhpharm-2023-003914"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-003914","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2024,1,25]]}}}